Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Enzene Biosciences Limited, is an unlisted public company incorporated on 28 August, 2006. It is classified as a public limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 60.00 cr and the total paid-up capital is INR 51.31 cr.
Enzene Biosciences Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's book networth has increased by 155.35%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Basudeo Narayan Singh | 00760310 | 14 years |
Director | Sandeep Singh | 01277984 | 14 years |
Director | Amit Avinash Ghare | 05103673 | 14 years |
Director | Prem Pavoor | 05268309 | 2 years |
Director | Sudha Ravi | 06764496 | 8 years |
Director | Sangeeta Kapil Jit Singh | 06920906 | 3 years |
Whole-time Director | Himanshu Shashikant Gadgil
Shareholder
|
07548149 | 8 years |
CEO | Himanshu Shashikant Gadgil | <HIDDEN> | 3 years |
Kmp | Yogita Arun Hanamshet | <HIDDEN> | 2 years |
CFO | Viral Pankajkumar Shah | <HIDDEN> | 7 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Export-Import Bank of India
No. of Loans: 1
Total Amount : 80.0 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 77.1 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 43.8 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 0.2 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Enzene INC | United States | - | - |
Read more
The incorporation date of ENZENE BIOSCIENCES LIMITED is 28 August, 2006
The authorized share capital of ENZENE BIOSCIENCES LIMITED is INR ₹ 60.0 Cr.
The paid-up capital of ENZENE BIOSCIENCES LIMITED is INR ₹ 51.3 Cr.
The registered address of ENZENE BIOSCIENCES LIMITED is Plot No A 22, A/1/2 Chakan Industrial Area, Phase 2, Khalu mbre, Chakan Pune Pune Maharashtra - 410501
The CIN number of ENZENE BIOSCIENCES LIMITED is U24232PN2006PLC165610.